Skip to main content

Table 1 Characteristics of the PDAC patients included in the study

From: Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Patient Code

Disease Stage

QT before CTC/KRAS cfDNA determination

KRAS cfDNA data

CTC data

CTC/KRAS cfDNA data

DNA concentration in plamsa (Average copies RNaseP/20ul plasma)

KRAS status in plasma

KRAS Mutation in plasma

Ratio M:WT KRAS in plasma

CTC STATUS

Number of CTC

CD45 Depletion KRAS mutation

Mutation in Tissue

1

R

YES

YES

  

80

NEG

     

G12D

2

R

YES

YES

  

43

NEG

     

G12R

3

R

YES

YES

  

59

NEG

      

4

R

NO

YES

YES

YES

106

NEG

  

NEG

0

  

5

R

NO

YES

YES

YES

97

NEG

  

NEG

0

WT

WT

6

R

NO

YES

YES

YES

185

POS

G12D

0,21

POS

1

 

G12D

7

R

NO

 

YES

     

NEG

0

WT

 

8

R

NO

 

YES

     

NEG

0

  

9

R

NO

YES

  

86

POS

G12D

0,1

  

WT

WT

10

R

NO

YES

YES

YES

93

POS

G12D

0,01

NEG

0

 

G12D

11

R

NO

YES

YES

YES

48

NEG

  

NEG

0

 

G12S

12

R

NO

YES

YES

YES

1541

NEG

  

NEG

0

  

13

R

NO

 

YES

     

NEG

0

  

14

R

NO

 

YES

     

NEG

0

  

15

LA

NO

YES

  

52

POS

G12V

0,12

    

16

LA

NO

YES

YES

yes

6,4

NEG

  

NEG

0

  

17

LA

NO

YES

YES

YES

66

NEG

  

NEG

0

G12D

 

18

LA

NO

YES

YES

YES

1063

NEG

  

NEG

0

  

19

LA

NO

 

YES

     

NEG

0

  

20

LA

YES

YES

  

297

NEG

      

21

LA

NO

YES

YES

YES

700

NEG

  

NEG

0

  

22

LA

YES

YES

YES

YES

38

NEG

  

NEG

0

  

23

LA

NO

YES

YES

YES

111

NEG

  

NEG

0

  

24

LA

NO

 

YES

     

NEG

0

  

25

LA

NO

 

YES

     

NEG

0

G12D

 

26

LA

NO

 

YES

     

NEG

0

  

27

LA

NO

 

YES

     

NEG

0

  

28

M

NO

YES

  

806

POS

G12D

0,06

    

29

M

NO

YES

YES

YES

12,2

NEG

  

NEG

0

  

30

M

YES

YES

YES

YES

1663

POS

G12D

2,43

POS

5

 

WT

31

M

NO

YES

YES

YES

72

NEG

  

NEG

0

 

WT

32

M

NO

YES

YES

YES

1095

POS

G12R

0,02

POS

4

 

G12R

33

M

NO

 

YES

     

NEG

0

  

34

M

NO

 

YES

     

NEG

0

  

35

M

NO

 

YES

     

POS

3

  

36

M

NO

YES

  

130

NEG

      

37

M

NO

YES

  

147

NEG

    

G12D

 

38

M

YES

YES

  

87

NEG

     

G12D

39

M

NO

YES

YES

YES

33

NEG

  

NEG

0

 

WT

40

M

NO

YES

YES

YES

328

NEG

  

NEG

0

G12D

 

41

M

NO

YES

YES

YES

602

POS

G12D

0,81

POS

3

  

42

M

NO

YES

YES

YES

70

NEG

  

NEG

0

WT

 

43

M

NO

YES

YES

YES

52

NEG

  

POS

1

WT

 

44

M

NO

 

YES

     

NEG

0

  

45

M

NO

 

YES

     

POS

13

  
  1. R Resectable, LA Locally Advanced, M Metastatic